Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « AbsEn.i » - entrée « molecular »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
mol < molecular < molecule  Facettes :

List of bibliographic references indexed by molecular

Number of relevant bibliographic references: 50.
[20-40] [0 - 20][0 - 50][40-49][40-60]
Ident.Authors (with country if any)Title
000B02 (2020) Francesca Angileri [France] ; Sébastien Legare [France] ; Antonella Marino Gammazza [Italie] ; Everly Conway De Macario [États-Unis] ; Alberto Jl Macario [Italie] ; Francesco Cappello [Italie]Molecular mimicry may explain multi-organ damage in COVID-19.
000B03 (2020) A. Bal [France] ; G. Destras [France] ; A. Gaymard [France] ; M. Bouscambert-Duchamp [France] ; M. Valette [France] ; V. Escuret [France] ; E. Frobert [France] ; G. Billaud [France] ; S. Trouillet-Assant [France] ; V. Cheynet [France] ; K. Brengel-Pesce [France] ; F. Morfin [France] ; B. Lina [France] ; L. Josset [France]Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del).
000B50 (2020) Ranim El Baba [France, Liban] ; Georges Herbein [France]Management of epigenomic networks entailed in coronavirus infections and COVID-19.
000B60 (2020) George W. Booz [États-Unis] ; Raffaele Altara [Norvège] ; Ali H. Eid [Liban] ; Zena Wehbe ; Souha Fares [Liban] ; Hassan Zaraket [Liban] ; Nada J. Habeichi [France] ; Fouad A. Zouein [Liban]Macrophage responses associated with COVID-19: A pharmacological perspective.
000C07 (2020) Chantal B E M. Reusken [Pays-Bas] ; Eeva K. Broberg [Suède] ; Bart Haagmans [Pays-Bas] ; Adam Meijer [Pays-Bas] ; Victor M. Corman [Allemagne] ; Anna Papa [Grèce] ; Remi Charrel [France] ; Christian Drosten [Allemagne] ; Marion Koopmans [Pays-Bas] ; Katrin Leitmeyer [Suède] ; On Behalf Of Evd-LabNet And Erli-NetLaboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020.
000C25 (2020) Francesca Angileri [France] ; Sébastien Légaré [France] ; Antonella Marino Gammazza [Italie] ; Everly Conway De Macario [États-Unis] ; Alberto J L. Macario [États-Unis, Italie] ; Francesco Cappello [Italie]Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?
000C51 (2020) Margarida Sa Ribero [France] ; Nolwenn Jouvenet [France] ; Marlène Dreux [France] ; Sébastien Nisole [France]Interplay between SARS-CoV-2 and the type I interferon response.
000D02 (2020) T. Joshi [Inde] ; T. Joshi ; P. Sharma ; S. Mathpal ; H. Pundir ; V. Bhatt ; S. ChandraIn silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking.
000D64 (2020) Bernadette Van Den Hoogen [Pays-Bas] ; Angela Santoni [Italie] ; Giuseppe Sciumé [Italie] ; Andrew Bowie [Irlande (pays)] ; Cliona O'Farrelly [Irlande (pays)] ; Luke O'Neill [Irlande (pays)] ; Marit Anthonsen [Norvège] ; Katerina Pardali [Suède] ; Simon Young [Suède] ; Andreas Bergthaler [Autriche] ; Nicolas Manel [France] ; Roland Zahn [Pays-Bas] ; Marjolein Kikkert [Pays-Bas] ; Eric Snijder [Pays-Bas] ; Frank Van Kuppeveld [Pays-Bas] ; Ron Fouchier [Pays-Bas] ; John Hiscott [Italie]Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
000D67 (2020) Emilie Deruelle [France] ; Omar Ben Hadj Salem [France] ; Sonnthida Sep Hieng [France] ; Claire Pichereau [France] ; Hervé Outin [France] ; Matthieu Jamme [France]Immune thrombocytopenia in a patient with COVID-19.
000D88 (2020) Reinhold Kreutz [Allemagne] ; Engi Abd El-Hady Algharably [Allemagne] ; Michel Azizi [France] ; Piotr Dobrowolski [Pologne] ; Tomasz Guzik [Pologne] ; Andrzej Januszewicz [Pologne] ; Alexandre Persu [Belgique] ; Aleksander Prejbisz [Pologne] ; Thomas Günther Riemer [Allemagne] ; Ji-Guang Wang [République populaire de Chine] ; Michel Burnier [Suisse]Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
000E02 (2020) Antonella Marino Gammazza [Italie] ; Sébastien Légaré [France] ; Giosuè Lo Bosco [Italie] ; Alberto Fucarino [Italie] ; Francesca Angileri [France] ; Everly Conway De Macario [États-Unis] ; Alberto Jl Macario [États-Unis, Italie] ; Francesco Cappello [Italie]Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19.
000E54 (2020) Evangelos Terpos [Grèce] ; Ioannis Ntanasis-Stathopoulos [Grèce] ; Ismail Elalamy [France, Russie] ; Efstathios Kastritis [Grèce] ; Theodoros N. Sergentanis [Grèce] ; Marianna Politou [Grèce] ; Theodora Psaltopoulou [Grèce] ; Grigoris Gerotziafas [France] ; Meletios A. Dimopoulos [Grèce]Hematological findings and complications of COVID-19.
000E57 (2020) Boris Pastorino [France] ; Franck Touret [France] ; Magali Gilles [France] ; Xavier De Lamballerie [France] ; Remi N. Charrel [France]Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?
000E81 (2020) Grigoris T. Gerotziafas [France] ; Mariella Catalano [Italie] ; Mary-Paula Colgan [Irlande (pays)] ; Zsolt Pecsvarady [Hongrie] ; Jean Claude Wautrecht [Belgique] ; Bahare Fazeli [Iran] ; Dan-Mircea Olinic [Roumanie] ; Katalin Farkas [Hongrie] ; Ismail Elalamy [France, Russie] ; Anna Falanga [Italie] ; Jawed Fareed [États-Unis] ; Chryssa Papageorgiou [France] ; Rosella S. Arellano ; Petros Agathagelou [Chypre (pays)] ; Darco Antic [Serbie] ; Luciana Auad [Argentine] ; Ljiljana Banfic [Croatie] ; John R. Bartolomew [États-Unis] ; Bela Benczur [Hongrie] ; Melissa B. Bernardo ; Francesco Boccardo [Italie] ; Renate Cifkova [République tchèque] ; Benilde Cosmi [Italie] ; Sergio De Marchi [Italie] ; Evangelos Dimakakos [Grèce] ; Meletios A. Dimopoulos [Grèce] ; Gabriel Dimitrov [Italie] ; Isabelle Durand-Zaleski [France] ; Michael Edmonds [Royaume-Uni] ; Essam Abo El Nazar [Arabie saoudite] ; Dilek Erer [Turquie] ; Omar L. Esponda [États-Unis] ; Paolo Gresele [Italie] ; Michael Gschwandtner [Autriche] ; Yongquan Gu ; M Nica Heinzmann [Argentine] ; Naomi M. Hamburg [États-Unis] ; Amer Hamadé [Arabie saoudite] ; Noor-Ahmed Jatoi [France] ; Oguz Karahan [Turquie] ; Debora Karetova [République tchèque] ; Thomas Karplus [Australie] ; Peter Klein-Weigel [Allemagne] ; Endre Kolossvary [Hongrie] ; Matija Kozak [Slovénie] ; Eleftheria Lefkou [Grèce] ; Gianfranco Lessiani [Italie] ; Aaron Liew [Irlande (pays)] ; Antonella Marcoccia [Italie] ; Peter Marshang [Italie] ; George Marakomichelakis [Grèce] ; Jiri Matuska [République tchèque] ; Luc Moraglia [France] ; Sergio Pillon [Italie] ; Pavel Poredos [Slovénie] ; Manlio Prior [Italie] ; David Raymund K. Salvador ; Oliver Schlager [Autriche] ; Gerit Schernthaner [Autriche] ; Alexander Sieron [Pologne] ; Jonas Spaak [Suède] ; Alex Spyropoulos [États-Unis] ; Muriel Sprynger [Belgique] ; Dusan Suput [Slovénie] ; Agata Stanek [Pologne] ; Viera Stvrtinova ; Andrzej Szuba [Pologne] ; Alfonso Tafur [États-Unis] ; Patrick Vandreden [France] ; Panagiotis E. Vardas [Grèce] ; Dragan Vasic [Serbie] ; Miikka Vikkula [Belgique] ; Paul Wennberg [États-Unis] ; Zhenguo Zhai [République populaire de Chine]Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.
000E89 (2020) Christian Bailly [France] ; Gérard Vergoten [France]Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?
000F51 (2020) Natesh Singh [France] ; Ludovic Chaput [France] ; Bruno O. Villoutreix [France]Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein-Protein Interfaces.
000F97 (2020) Boris Pastorino [France] ; Franck Touret [France] ; Magali Gilles [France] ; Lea Luciani [France] ; Xavier De Lamballerie [France] ; Remi N. Charrel [France]Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples.
001131 (2020) Ferdinando D'Amico [France] ; Daniel C. Baumgart [Canada] ; Silvio Danese [Italie] ; Laurent Peyrin-Biroulet [France]Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management.
001141 (2020) Laura Pezzi [France] ; Remi N. Charrel [France] ; Laetitia Ninove [France] ; Antoine Nougairede [France] ; Gregory Molle [France] ; Bruno Coutard [France] ; Guillaume Durand [France] ; Isabelle Leparc-Goffart [France] ; Xavier De Lamballerie [France] ; Laurence Thirion [France]Development and Evaluation of a duo SARS-CoV-2 RT-qPCR Assay Combining Two Assays Approved by the World Health Organization Targeting the Envelope and the RNA-Dependant RNA Polymerase (RdRp) Coding Regions.
001201 (2020) Cédric Annweiler ; Zhijian Cao [République populaire de Chine] ; Yingliang Wu [République populaire de Chine] ; Emmanuelle Faucon ; Stéphanie Mouhat ; Hervé Kovacic ; Jean-Marc SabatierCounter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "molecular" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "molecular" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    molecular
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021